Clinical Trial

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients

Study acronym: SMART II
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Trial Details
NCT Number NCT07273513
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions Hypertension, Diabete Mellitus, Hyperlipidemia, Post PCI, Post CABG
Enrollment 951 participants
Start Date 2026-01-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-18